Cancer Infectious Diseases Neurological Disorders Respiratory Diseases COVID-19 Hantavirus Pulmonary Syndrome Hantavirus Genetic Disorders Diabetes Pneumonia
Researchers are preparing human trials of letrozole and irinotecan after electronic health data linked the combo to lower Alzheimer’s risk, mindful of its side-effect profile